Effect of edrophonium and neostigmine on the pharmacokinetics and neuromuscular effects of mivacurium

Anesthesiology

Volumn 92, Issue 3, 2000, Pages 708-714

  Szenohradszky, Janos ^a   Fogarty, Declan ^b   Kirkegaard Nielsen, Hans ^c   Brown, Ronald ^e   Sharma, Manohar L ^e   Fisher, Dennis M ^d  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NONE

Author keywords

Antagonists; Drug interaction; Muscle relaxants

Indexed keywords

ATROPINE; EDROPHONIUM; MIVACURIUM; NEOSTIGMINE; SODIUM CHLORIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG METABOLISM; HUMAN; MUSCLE RELAXATION; MUSCLE TONE; MUSCLE TWITCH; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034009559     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200003000-00015     Document Type: Article

References (19)

1. Hart PS, Wright PMC, Brown R, Lau M, Sharma M, Miller RD, Gruenke L, Fisher DM: Edrophonium increases mivacurium concentrations during constant mivacurium infusion and large doses minimally antagonize paralysis. ANESTHESIOLOGY 1995; 82:912-8
2. Szenohradszky J, Lau M, Brown R, Sharma ML, Fisher DM: The effect of neostigmine on twitch tension and muscle relaxant concentration during infusion of mivacurium or vecuronium. ANESTHESIOLOGY 1995; 83:83-7
3. Lacroix M, Donati F, Varin F: Pharmacokinetics of mivacurium isomers and their metabolites in healthy volunteers after intravenous bolus administration. ANESTHESIOLOGY 1997; 86:322-30
4. Lee GC, Iyengar S, Szenohradszky J, Caldwell JE, Wright PMC, Brown R, Lau M, Luks A, Fisher DM: Improving the design of muscle relaxant studies. Stabilization period and tetanic recruitment. ANESTHESIOLOGY 1997; 86:48-54
5. Brown AR, James CD, Welch RM, Harrelson JC: Stereoselective high-performance liquid chromatographic assay with fluorometric detection for the isomers of mivacurium in human plasma. J Chromatogr 1992; 578:302-8
6. Baurain MJ, Dernovoi BS, d'Hollander AA, Hennart DA: Comparison of neostigmine-induced recovery with spontaneous recovery from mivacurium-induced neuromuscular block. Br J Anaesth 1994; 73: 791-4
7. Connolly FM, Mirakhur RK, Loan PB, McCoy EP, Symington M, Kumar N: Antagonism of mivacurium block with edrophonium from various degrees of spontaneous recovery. Br J Anaesth 1995; 74: 229-30
8. Devcic A, Munshi CA, Gandhi SK, Kampine JP, Lessard MR, Trepanier CA, Rouillard JF: Antagonism of mivacurium neuromuscular block: neostigmine versus edrophonium. Anesth Analg 1995; 81:1005-9
9. Kao YJ, Le ND: The reversal of profound mivacurium-induced neuromuscular blockade. Can J Anaesth 1996; 43:1128-33
10. Lessard MR, Trepanier CA, Rouillard JF: Neostigmine requirements for reversal of neuromuscular blockade following an infusion of mivacurium. Can J Anaesth 1997; 44:836-42
11. Maddineni VR, Mirakhur RK, McCoy EP: Recovery of mivacurium block with or without anticholinesterases following administration by continuous infusion. Anaesthesia 1994; 49:946-8
12. Marcotte J, Drolet P, Perreault L, Girard M: Dose-response relationships for edrophonium antagonism of mivacurium-induced neuromuscular block during N2O-enflurane-alfentanil anaesthesia. Can J Anaesth 1995; 42:879-83
13. Miller DR, Bryson G, Martineau RJ, Kitts JB, Curran M, Bragg P, Watson JB, Hull K, Lindsay P: Edrophonium requirements for reversal of deep neuromuscular block following infusion of mivacurium. Can J Anaesth 1995; 42:996-1002
14. 2O, de propofol et d'alfentanil. Can J Anaesth 1996; 43:368-72
15. Trévien V, Lienhart A, Just B, Chandon M, Baras E, Camatte S: Effect of neostigmine at different levels of mivacurium-induced neuromuscular blockade. Acta Anaesthesiol Scand Suppl 1995; 106:66-9
16. Magorian TT, Lynam DP, Caldwell JE, Miller RD: Can early administration of neostigmine, in single or repeated doses, alter the course of neuromuscular recovery from a vecuronium-induced neuromuscular blockade? ANESTHESIOLOGY 1990;73:410-4
17. Savarese J, Lien C, Belmont M: Antagonism of residual mivacurium blockade: Setting the record straight. ANESTHESIOLOGY 1996; 84: 1525-7
18. Lien CA, Schmith VD, Embree PB, Belmont MR, Wargin WA, Savarese JJ: The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/ barbiturate anesthesia. ANESTHESIOLOGY 1994; 80:1296-302
19. Hart PS, McCarthy GJ, Brown R, Lau M, Fisher DM: The effect of plasma cholinesterase activity on mivacurium infusion rates. Anesth Analg 1995; 80:760-3